Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
84°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Arcus Biosciences Inc
(NY:
RCUS
)
14.47
+0.19 (+1.33%)
Official Closing Price
Updated: 4:10 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcus Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Taiho Pharmaceutical Exercises Option for an Exclusive License to Arcus Biosciences’ Anti-TIGIT Program in Japan and Certain Territories in Asia
November 30, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences to Participate in the Upcoming Evercore ISI HealthCONx 2021 Conference
November 22, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Stock Rockets To Record As Gilead Unexpectedly Opts Into Cancer Drugs
November 18, 2021
Gilead opted into three programs from a small biotech company, sending shares flying.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Intraday Session
November 18, 2021
Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA) shares moved upwards by 78.87% to $38.06 during Thursday's regular session. As of 12:30 EST, this security is trading at...
Via
Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
August 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
54 Biggest Movers From Yesterday
November 19, 2021
Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company...
Via
Benzinga
Exposures
Product Safety
44 Stocks Moving In Thursday's Mid-Day Session
November 18, 2021
Gainers Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the...
Via
Benzinga
Exposures
Product Safety
Why Are Arcus Biosciences Shares Trading Higher Today?
November 18, 2021
Gilead Sciences Inc (NASDAQ: GILD) has exercised its options to three programs in Arcus Biosciences Inc (NYSE: RCUS) portfolio, including both anti-TIGIT...
Via
Benzinga
Why Arcus Biosciences Stock Is On Fire Today
November 18, 2021
Gilead Sciences has decided to exercise its options for three of the biotech's oncology programs.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 18, 2021
Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA) stock increased by 78.28% to $37.94 during Thursday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
Gilead Exercises Options to Three Arcus Biosciences Clinical-Stage Programs and Adds Research Collaboration
November 18, 2021
From
Gilead Sciences, Inc.
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
November 09, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Recap: Arcus Biosciences Q3 Earnings
November 08, 2021
Arcus Biosciences (NYSE:RCUS) reported its Q3 earnings results on Monday, November 8, 2021 at 04:10 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Arcus Biosciences Reports Third Quarter 2021 Financial Results and Provides an Update on our anti-TIGIT Domvanalimab
November 08, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences to Report Third Quarter 2021 Financial Results & Recent Corporate Highlights
November 02, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Earnings Scheduled For November 8, 2021
November 08, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •...
Via
Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
October 26, 2021
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
October 11, 2021
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
September 27, 2021
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
September 09, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences to Participate at Upcoming Investor Conferences
September 01, 2021
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
August 24, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
August 10, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Reports Second Quarter 2021 Financial Results and Provides Operational Highlights
August 05, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences to Participate at the 2021 Wedbush PacGrow Virtual Healthcare Conference
August 04, 2021
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences to Report Second Quarter 2021 Financial Results & Recent Corporate Highlights
July 29, 2021
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
July 26, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
Arcus Surges As Executive Transfer Could Signal Deeper Gilead Partnership
July 20, 2021
An Arcus executive jumped ship for a role at Gilead, but RCUS stock popped Tuesday on expectations for a closer relationship.
Via
Investor's Business Daily
Arcus Biosciences Announces New Employment Inducement Grants
July 12, 2021
From
Arcus Biosciences
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.